Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results Benzinga SOUTH SAN FRANCISCO, Calif., April 1, 2019 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today reported financial results for the fourth …
LEAP THERAPEUTICS, INC. files 10-K | Thorold News Thorold News LEAP THERAPEUTICS, INC. files 10-K in a filing on Apr 01.Esophageal cancer, or EC, and gastric cancer, or GC, are malignancies of the digestive tract. The.
LEAP THERAPEUTICS, INC. files 10-K | Thorold News – Thorold News Read More »
Precision Therapeutics Inc. filed 10-K | Thorold News Thorold News Precision Therapeutics Inc. revealed 10-K form on Monday, Apr 01. · Precision has acquired 25% of the capital stock of Helomics and intends to consummate a.
Precision Therapeutics Inc. filed 10-K | Thorold News – Thorold News Read More »
Vislink Technologies, Inc. files 10-K | Thorold News Thorold News Vislink Technologies, Inc. filed 10-K with SEC. Read ‘s full filing at 000149315219004520.As of June 30, 2018, the last business day of the registrant’s most.
Vislink Technologies, Inc. files 10-K | Thorold News – Thorold News Read More »
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update Nasdaq GAITHERSBURG, Md., April 01, 2019– Altimmune, Inc., a clinical-stage immunotherapeutics company, today announced financial results for the year.
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. GlobeNewswire BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) — Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) …
GrowGeneration Reports Record 2018 Revenues Canada NewsWire Sets 2019 Revenue Guidance at $52M-58M, Adjusted EBITDA of $.12-$.16 per share DENVER, CO, April 1, 2019 /CNW/ – GrowGeneration Corp. (OTCQX: …
GrowGeneration Reports Record 2018 Revenues – Canada NewsWire Read More »
Flower One Announces Full Exercise of Over-Allotment Option Resulting in a Public Offering for Gross Proceeds of $57.5 Million Canada NewsWire NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ TORONTO, April 1, 2019 /CNW/ …
Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Citius Pharmaceuticals Inc. (Nasdaq: CTXR), …